{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:10:42Z","timestamp":1751083842317,"version":"3.41.0"},"reference-count":33,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objectives: This study explores the relationship between inhaler visual identification, naming, and adherence outcomes, and evaluates the potential of combining these factors into a screening tool for identifying poor adherence. Methods: This observational, prospective study included adult patients with COPD, asthma, or asthma+COPD who had been on chronic inhalation therapy for at least the past year. Data were collected through patient interviews and medical records. Adherence was assessed using the Test of Adherence to Inhalers (TAI) questionnaire and prescription records, calculated as the Proportion of Days Covered (PDC). The patients completed a questionnaire to evaluate their ability to visually identify and name their inhalers. Results: Among the 196 participants, significant differences in adherence levels were observed across the COPD, asthma, and asthma+COPD groups, with COPD patients demonstrating higher adherence rates (p=0.001). Concordance between TAI and PDC was highest in the COPD group (75.0%), compared to the asthma (51.3%) and asthma+COPD (55.5%) groups. Correct naming of inhalers was not significantly correlated with adherence. However, correct inhaler visual identification was associated with better adherence. Incorrect visual identification showed low sensitivity (15.9%) but high specificity (92.6%) for detecting poorly adherent patients. Conclusions: The ability to visually identify inhalers was associated with better adherence, while the ability to name inhalers was not. Although incorrect visual identification has limited utility as a screening tool, it may still serve as a rapid and practical method for identifying poorly adherent patients in clinical practice.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250393","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T21:50:40Z","timestamp":1751061040000},"page":"e20250393","source":"Crossref","is-referenced-by-count":0,"title":["Inhaler identification: evaluating a potential screening method for adherence in chronic respiratory disease management"],"prefix":"10.36416","author":[{"given":"David","family":"Silva Gomes1","sequence":"first","affiliation":[{"name":"1. Departamento de Pneumologia do Hospital Infante D. Pedro, Unidade Local de Sa\u00fade da Regi\u00e3o de Aveiro, Aveiro, Portugal."}]},{"given":"Carlos","family":"Seixas2,3","sequence":"additional","affiliation":[{"name":"2. Portucalense University, Research on Economics, Management and Information Technologies, REMIT, Porto, Portugal. 3. Centro de Economia e Finan\u00e7as, Universidade do Porto, Porto, Portugal."}]},{"given":"Jo\u00e3o","family":"Cravo1","sequence":"additional","affiliation":[{"name":"1. Departamento de Pneumologia do Hospital Infante D. Pedro, Unidade Local de Sa\u00fade da Regi\u00e3o de Aveiro, Aveiro, Portugal."}]}],"member":"22288","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref0","unstructured":"1.           Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report. Available from: www.goldcopd.org."},{"key":"ref1","unstructured":"2.           Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024. Updated May 2024. Available from: www.ginasthma.org."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           M\u00e4kel\u00e4 MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481\u201390. https:\/\/doi.org\/10.1016\/j.rmed.2013.04.005.","DOI":"10.1016\/j.rmed.2013.04.005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           van Boven JFM, Chavannes NH, van der Molen T, Rutten-van M\u00f6lken MPMH, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108(1):103\u201313. https:\/\/doi.org\/10.1016\/j.rmed.2013.08.044.","DOI":"10.1016\/j.rmed.2013.08.044"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.           Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(6):1185\u20131191.e2. https:\/\/doi.org\/10.1016\/j.jaci.2011.09.011.","DOI":"10.1016\/j.jaci.2011.09.011"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.           Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105(3):435\u201341. https:\/\/doi.org\/10.1016\/j.rmed.2010.09.006.","DOI":"10.1016\/j.rmed.2010.09.006"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939\u201343. https:\/\/doi.org\/10.1136\/thx.2009.113662.","DOI":"10.1136\/thx.2009.113662"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67(8):751\u20133. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-201096.","DOI":"10.1136\/thoraxjnl-2011-201096"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.           Antoniu SA. Adherence to inhaled therapy in COPD: effects on survival and exacerbations. Expert Rev Pharmacoecon Outcomes Res. 2010;10(2):115\u20137. https:\/\/doi.org\/10.1586\/erp.10.10.","DOI":"10.1586\/erp.10.10"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24(1):14009. https:\/\/doi.org\/10.1038\/npjpcrm.2014.9.","DOI":"10.1038\/npjpcrm.2014.9"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396\u2013407. https:\/\/doi.org\/10.1183\/09031936.00075614.","DOI":"10.1183\/09031936.00075614"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.        Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36(1):55\u201369. https:\/\/doi.org\/10.1007\/s11096-013-9865-x.","DOI":"10.1007\/s11096-013-9865-x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005;25(1):107\u201330. https:\/\/doi.org\/10.1016\/j.iac.2004.09.005.","DOI":"10.1016\/j.iac.2004.09.005"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        \u015awi\u0105toniowska N, Chabowski M, Pola\u0144ski J, Mazur G, Jankowska-Pola\u0144ska B. Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review. Adv Exp Med Biol. 2020;1271:37\u201347. https:\/\/doi.org\/10.1007\/5584_2019_477.","DOI":"10.1007\/5584_2019_477"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Monteiro C, Maricoto T, Prazeres F, Augusto Sim\u00f5es P, Augusto Sim\u00f5es J. Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respir Med. 2022;191:106724. https:\/\/doi.org\/10.1016\/j.rmed.2021.106724.","DOI":"10.1016\/j.rmed.2021.106724"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Vrijens B, Dima AL, Van Ganse E, van Boven JFM, Eakin MN, Foster JM, et al. What We Mean When We Talk About Adherence in Respiratory Medicine. J Allergy Clin Immunol Pract. 2016;4(5):802\u201312. https:\/\/doi.org\/10.1016\/j.jaip.2016.05.019.","DOI":"10.1016\/j.jaip.2016.05.019"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Plaza V, Fern\u00e1ndez-Rodr\u00edguez C, Melero C, Cos\u00edo BG, Entrenas LM, de Llano LP, et al. Validation of the \u2018Test of the Adherence to Inhalers\u2019 (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142\u201352. https:\/\/doi.org\/10.1089\/jamp.2015.1212.","DOI":"10.1089\/jamp.2015.1212"},{"key":"ref17","unstructured":"18.        Nau DP. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. Springfield, VA Pharm Qual Alliance. 2012;6:25."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.        Baumgartner PC, Haynes RB, Hersberger KE, Arnet I. A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes. Front Pharmacol. 2018;9:1290. https:\/\/doi.org\/10.3389\/fphar.2018.01290.","DOI":"10.3389\/fphar.2018.01290"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Plaza V, L\u00f3pez-Vi\u00f1a A, Entrenas LM, Fern\u00e1ndez-Rodr\u00edguez C, Melero C, P\u00e9rez-Llano L, et al. Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients. COPD: J Chron Obstr Pulm Dis. 2016;13(5):547\u201354. https:\/\/doi.org\/10.3109\/15412555.2015.1118449.","DOI":"10.3109\/15412555.2015.1118449"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.        Covvey JR, Mullen AB, Ryan M, Steinke DT, Johnston BF, Wood FT, et al. A comparison of medication adherence\/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract. 2014;68(10):1200\u20138. https:\/\/doi.org\/10.1111\/ijcp.12451.","DOI":"10.1111\/ijcp.12451"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        Paivio A, Csapo K. Picture superiority in free recall: Imagery or dual coding? Cogn Psychol. 1973;5(2):176\u2013206. https:\/\/doi.org\/10.1016\/0010-0285(73)90032-7.","DOI":"10.1016\/0010-0285(73)90032-7"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.        Paivio A, Rogers TB, Smythe PC. Why are pictures easier to recall than words? Psychon Sci. 1968;11(4):137\u20138. Available from: https:\/\/doi.org\/10.3758\/BF03331011.","DOI":"10.3758\/bf03331011"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.        Brady TF, Konkle T, Alvarez GA, Oliva A. Visual long-term memory has a massive storage capacity for object details. Proc Natl Acad Sci U S A. 2008;105(38):14325\u20139. https:\/\/doi.org\/10.1073\/pnas.0803390105.","DOI":"10.1073\/pnas.0803390105"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.        Leiva-Fern\u00e1ndez J, Leiva-Fern\u00e1ndez F, Garc\u00eda-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med. 2014;14(1):70. https:\/\/doi.org\/10.1186\/1471-2466-14-70.","DOI":"10.1186\/1471-2466-14-70"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.        Yu AP, Gu\u00e9rin A, Ponce de Leon D, Ramakrishnan K, Wu EQ, Mocarski M, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486\u201396. https:\/\/doi.org\/10.3111\/13696998.2011.594123.","DOI":"10.3111\/13696998.2011.594123"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.        Bogart M, Stanford RH, Lalibert\u00e9 F, Germain G, Wu JW, Duh MS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343\u201352. https:\/\/doi.org\/10.2147\/COPD.S184653.","DOI":"10.2147\/COPD.S184653"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.        Mannino D, Bogart M, Wu B, Germain G, Lalibert\u00e9 F, MacKnight SD, et al. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. Respir Med. 2022;197:106807. https:\/\/doi.org\/10.1016\/j.rmed.2022.106807.","DOI":"10.1016\/j.rmed.2022.106807"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.        Deslee G, Fabry-Vendrand C, Poccardi N, Thabut G, Eteve Pitsaer C, Coriat A, et al. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study). BMJ Open Respir Res. 2023;10(1):e001585. https:\/\/doi.org\/10.1136\/bmjresp-2022-001585.","DOI":"10.1136\/bmjresp-2022-001585"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.        Vanoverschelde A, van der Wel P, Putman B, Lahousse L. Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies. BMJ Open Respir Res. 2021;8(1):e000823. https:\/\/doi.org\/10.1136\/bmjresp-2020-000823.","DOI":"10.1136\/bmjresp-2020-000823"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.        Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017;27(1):22. https:\/\/doi.org\/10.1038\/s41533-017-0016-z.","DOI":"10.1038\/s41533-017-0016-z"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.        Montes de Oca M, Menezes A, Wehrmeister FC, Lopez Varela MV, Casas A, Ugalde L, et al. Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study. PLoS One. 2017;12(11):e0186777. https:\/\/doi.org\/10.1371\/journal.pone.0186777.","DOI":"10.1371\/journal.pone.0186777"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.        Hayes-Watson C, Nuss H, Tseng TS, Parada N, Yu Q, Celestin M, et al. Self-management practices of smokers with asthma and\/or chronic obstructive pulmonary disease: a cross-sectional survey. COPD Res Pract. 2017;3(1):3. https:\/\/doi.org\/10.1186\/s40749-017-0022-0.","DOI":"10.1186\/s40749-017-0022-0"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T21:50:44Z","timestamp":1751061044000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4116\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":33,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250393","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}